Aberrant DNA replication in cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 743-744, Issue , 2013, Pages 111-117

  Suzuki, Motoshi ^a   Takahashi, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; DNA repair; DNA replication; Genomic instability; Translesion DNA synthesis

Indexed keywords

RAD18 PROTEIN; RAD6 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS;

EID: 84877924200     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2012.07.003     Document Type: Review

References (129)

1. Aguilera A., Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat. Rev. Genet. 2008, 9:204-217.
2. Alabert C., Groth A. Chromatin replication and epigenome maintenance. Nat. Rev. Mol. Cell Biol. 2012, 13:153-167.
3. Blow J.J., Gillespie P.J. Replication licensing and cancer-a fatal entanglement?. Nat. Rev. Cancer 2008, 8:799-806.
4. Hoffmann J.S., Cazaux C. Aberrant expression of alternative DNA polymerases: a source of mutator phenotype as well as replicative stress in cancer. Semin. Cancer Biol. 2010, 20:312-319.
5. Masai H., Matsumoto S., You Z., Yoshizawa-Sugata N., Oda M. Eukaryotic chromosome DNA replication: where, when, and how?. Annu. Rev. Biochem. 2010, 79:89-130.
6. McGeoch A.T., Bell S.D. Extra-chromosomal elements and the evolution of cellular DNA replication machineries. Nat. Rev. Mol. Cell Biol. 2008, 9:569-574.
7. Ohmori H., Hanafusa T., Ohashi E., Vaziri C. Separate roles of structured and unstructured regions of Y-family DNA polymerases. Adv. Protein Chem. Struct. Biol. 2009, 78:99-146.
8. Prakash S., Johnson R.E., Prakash L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 2005, 74:317-353.
9. Stallons L.J., McGregor W.G. Translesion synthesis polymerases in the prevention and promotion of carcinogenesis. J. Nucleic Acids 2010, 2010. Article ID 643857. 10.4061/2010/643857.
10. Sweasy J.B., Lauper J.M., Eckert K.A. DNA polymerases and human diseases. Radiat. Res. 2006, 166:693-714.
11. Unk I., Hajdu I., Blastyak A., Haracska L. Role of yeast Rad5 and its human orthologs, HLTF and SHPRH in DNA damage tolerance. DNA Repair (Amst.) 2010, 9:257-267.
12. Sheu Y.J., Stillman B. Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. Mol. Cell 2006, 24:101-113.
13. Masai H., Taniyama C., Ogino K., Matsui E., Kakusho N., Matsumoto S., Kim J.M., Ishii A., Tanaka T., Kobayashi T., Tamai K., Ohtani K., Arai K. Phosphorylation of MCM4 by Cdc7 kinase facilitates its interaction with Cdc45 on the chromatin. J. Biol. Chem. 2006, 281:39249-39261.
14. Krasinska L., Besnard E., Cot E., Dohet C., Mechali M., Lemaitre J.M., Fisher D. Cdk1 and Cdk2 activity levels determine the efficiency of replication origin firing in Xenopus. EMBO J. 2008, 27:758-769.
15. Francis L.I., Randell J.C., Takara T.J., Uchima L., Bell S.P. Incorporation into the prereplicative complex activates the Mcm2-7 helicase for Cdc7-Dbf4 phosphorylation. Genes Dev. 2009, 23:643-654.
16. Nishitani H., Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells 2002, 7:523-534.
17. Saxena S., Dutta A. Geminin-Cdt1 balance is critical for genetic stability. Mutat. Res. 2005, 569:111-121.
18. Labib K., Gambus A. A key role for the GINS complex at DNA replication forks. Trends Cell Biol. 2007, 17:271-278.
19. Gambus A., Jones R.C., Sanchez-Diaz A., Kanemaki M., van Deursen F., Edmondson R.D., Labib K. GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks. Nat. Cell Biol. 2006, 8:358-366.
20. Thangavel S., Mendoza-Maldonado R., Tissino E., Sidorova J.M., Yin J., Wang W., Monnat R.J., Falaschi A., Vindigni A. Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol. Cell. Biol. 2010, 30:1382-1396.
21. Sangrithi M.N., Bernal J.A., Madine M., Philpott A., Lee J., Dunphy W.G., Venkitaraman A.R. Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome. Cell 2005, 121:887-898.
22. Elble R., Tye B.K. Chromosome loss, hyperrecombination, and cell cycle arrest in a yeast mcm1 mutant. Mol. Biol. Cell 1992, 3:971-980.
23. Shima N., Alcaraz A., Liachko I., Buske T.R., Andrews C.A., Munroe R.J., Hartford S.A., Tye B.K., Schimenti J.C. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat. Genet. 2007, 39:93-98.
24. Kawabata T., Luebben S.W., Yamaguchi S., Ilves I., Matise I., Buske T., Botchan M.R., Shima N. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol. Cell 2011, 41:543-553.
25. Pruitt S.C., Bailey K.J., Freeland A. Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer. Stem Cells 2007, 25:3121-3132.
26. Hartford S.A., Luo Y., Southard T.L., Min I.M., Lis J.T., Schimenti J.C. Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17702-17707.
27. Waga S., Stillman B. The DNA replication fork in eukaryotic cells. Annu. Rev. Biochem. 1998, 67:721-751.
28. Suzuki M., Savoysky E., Izuta S., Tatebe M., Okajima T., Yoshida S. RNA priming coupled with DNA synthesis on natural template by calf thymus DNA polymerase alpha-primase. Biochemistry 1993, 32:12782-12792.
29. Suzuki M., Izuta S., Savoysky E., Sakurai T., Simbulan C., Tatebe M., Kojima K., Yoshida S. Deoxypyrimidine cluster mediates the priming by calf thymus DNA primase subunit. Biochem. Mol. Biol. Int. 1993, 29:645-652.
30. Wold M.S. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 1997, 66:61-92.
31. Pavlov Y.I., Frahm C., Nick McElhinny S.A., Niimi A., Suzuki M., Kunkel T.A. Evidence that errors made by DNA polymerase alpha are corrected by DNA polymerase delta. Curr. Biol. 2006, 16:202-207.
32. Tsurimoto T., Stillman B. Replication factors required for SV40 DNA replication in vitro. II. Switching of DNA polymerase alpha and delta during initiation of leading and lagging strand synthesis. J. Biol. Chem. 1991, 266:1961-1968.
33. Pursell Z.F., Isoz I., Lundstrom E.B., Johansson E., Kunkel T.A. Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 2007, 317:127-130.
34. Pavlov Y.I., Shcherbakova P.V. DNA polymerases at the eukaryotic fork-20 years later. Mutat. Res. 2010, 685:45-53.
35. Morrison A., Bell J.B., Kunkel T.A., Sugino A. Eukaryotic DNA polymerase amino acid sequence required for 3'5' exonuclease activity. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:9473-9477.
36. Morrison A., Johnson A.L., Johnston L.H., Sugino A. Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J. 1993, 12:1467-1473.
37. Niimi A., Limsirichaikul S., Yoshida S., Iwai S., Masutani C., Hanaoka F., Kool E.T., Nishiyama Y., Suzuki M. Palm mutants in DNA polymerases alpha and eta alter DNA replication fidelity and translesion activity. Mol. Cell. Biol. 2004, 24:2734-2746.
38. Nick McElhinny S.A., Stith C.M., Burgers P.M., Kunkel T.A. Inefficient proofreading and biased error rates during inaccurate DNA synthesis by a mutant derivative of Saccharomyces cerevisiae DNA polymerase delta. J. Biol. Chem. 2007, 282:2324-2332.
39. Venkatesan R.N., Hsu J.J., Lawrence N.A., Preston B.D., Loeb L.A. Mutator phenotypes caused by substitution at a conserved motif A residue in eukaryotic DNA polymerase delta. J. Biol. Chem. 2006, 281:4486-4494.
40. Tanaka S., Cao K., Niimi A., Limsirichaikul S., Miao H.Q., Nakamura N., Murate T., Hasegawa Y., Takahashi T., Suzuki M. Functions of base selection step in human DNA polymerase alpha. DNA Repair (Amst.) 2010, 9:534-541.
41. Goldsby R.E., Lawrence N.A., Hays L.E., Olmsted E.A., Chen X., Singh M., Preston B.D. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat. Med. 2001, 7:638-639.
42. Albertson T.M., Ogawa M., Bugni J.M., Hays L.E., Chen Y., Wang Y., Treuting P.M., Heddle J.A., Goldsby R.E., Preston B.D. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17101-17104.
43. Venkatesan R.N., Treuting P.M., Fuller E.D., Goldsby R.E., Norwood T.H., Gooley T.A., Ladiges W.C., Preston B.D., Loeb L.A. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol. Cell. Biol. 2007, 27:7669-7682.
44. Ogawa M., Limsirichaikul S., Niimi A., Iwai S., Yoshida S., Suzuki M. Distinct function of conserved amino acids in the fingers of Saccharomyces cerevisiae DNA polymerase alpha. J. Biol. Chem. 2003, 278:19071-19078.
45. Kokoska R.J., Stefanovic L., DeMai J., Petes T.D. Increased rates of genomic deletions generated by mutations in the yeast gene encoding DNA polymerase delta or by decreases in the cellular levels of DNA polymerase delta. Mol. Cell. Biol. 2000, 20:7490-7504.
46. Liu V.F., Bhaumik D., Wang T.S. Mutator phenotype induced by aberrant replication. Mol. Cell. Biol. 1999, 19:1126-1135.
47. Lemoine F.J., Degtyareva N.P., Kokoska R.J., Petes T.D. Reduced levels of DNA polymerase delta induce chromosome fragile site instability in yeast. Mol. Cell. Biol. 2008, 28:5359-5368.
48. Lemoine F.J., Degtyareva N.P., Lobachev K., Petes T.D. Chromosomal translocations in yeast induced by low levels of DNA polymerase a model for chromosome fragile sites. Cell 2005, 120:587-598.
49. Chen C., Merrill B.J., Lau P.J., Holm C., Kolodner R.D. Saccharomyces cerevisiae pol30 (proliferating cell nuclear antigen) mutations impair replication fidelity and mismatch repair. Mol. Cell. Biol. 1999, 19:7801-7815.
50. Sugimoto K., Ando S., Shimomura T., Matsumoto K. Rfc5, a replication factor C component, is required for regulation of Rad53 protein kinase in the yeast checkpoint pathway. Mol. Cell. Biol. 1997, 17:5905-5914.
51. Tishkoff D.X., Filosi N., Gaida G.M., Kolodner R.D. A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair. Cell 1997, 88:253-263.
52. Wang Y., Putnam C.D., Kane M.F., Zhang W., Edelmann L., Russell R., Carrion D.V., Chin L., Kucherlapati R., Kolodner R.D., Edelmann W. Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat. Genet. 2005, 37:750-755.
53. Davies A.A., Huttner D., Daigaku Y., Chen S., Ulrich H.D. Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein A. Mol. Cell 2008, 29:625-636.
54. Tsuji Y., Watanabe K., Araki K., Shinohara M., Yamagata Y., Tsurimoto T., Hanaoka F., Yamamura K., Yamaizumi M., Tateishi S. Recognition of forked and single-stranded DNA structures by human RAD18 complexed with RAD6B protein triggers its recruitment to stalled replication forks. Genes Cells 2008, 13:343-354.
55. Watanabe K., Tateishi S., Kawasuji M., Tsurimoto T., Inoue H., Yamaizumi M. Rad18 guides pol eta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 2004, 23:3886-3896.
56. Niimi A., Brown S., Sabbioneda S., Kannouche P.L., Scott A., Yasui A., Green C.M., Lehmann A.R. Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16125-16130.
57. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419:135-141.
58. Stelter P., Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003, 425:188-191.
59. Motegi A., Liaw H.J., Lee K.Y., Roest H.P., Maas A., Wu X., Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H., Myung K. Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12411-12416.
60. Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K. Human SHPRH suppresses genomic instability through proliferating cell nuclear antigen polyubiquitination. J. Cell Biol. 2006, 175:703-708.
61. Blastyak A., Hajdu I., Unk I., Haracska L. Role of double-stranded DNA translocase activity of human HLTF in replication of damaged DNA. Mol. Cell. Biol. 2010, 30:684-693.
62. Chiu R.K., Brun J., Ramaekers C., Theys J., Weng L., Lambin P., Gray D.A., Wouters B.G. Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations. PLoS Genet. 2006, 2:e116.
63. Moraes T.F., Edwards R.A., McKenna S., Pastushok L., Xiao W., Glover J.N., Ellison M.J. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat. Struct. Biol. 2001, 8:669-673.
64. Unk I., Hajdu I., Fatyol K., Hurwitz J., Yoon J.H., Prakash L., Prakash S., Haracska L. Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3768-3773.
65. Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V., Hurwitz J., Prakash L., Prakash S., Haracska L. Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18107-18112.
66. Tateishi S., Niwa H., Miyazaki J., Fujimoto S., Inoue H., Yamaizumi M. Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells. Mol. Cell. Biol. 2003, 23:474-481.
67. Roest H.P., Baarends W.M., de Wit J., van Klaveren J.W., Wassenaar E., Hoogerbrugge J.W., van Cappellen W.A., Hoeijmakers J.H., Grootegoed J.A. The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice. Mol. Cell. Biol. 2004, 24:5485-5495.
68. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 1999, 399:700-704.
69. Masutani C., Araki M., Yamada A., Kusumoto R., Nogimori T., Maekawa T., Iwai S., Hanaoka F. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J. 1999, 18:3491-3501.
70. Johnson R.E., Kondratick C.M., Prakash S., Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 1999, 285:263-265.
71. Kannouche P., Broughton B.C., Volker M., Hanaoka F., Mullenders L.H., Lehmann A.R. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev. 2001, 15:158-172.
72. Rey L., Sidorova J.M., Puget N., Boudsocq F., Biard D.S., Monnat R.J., Cazaux C., Hoffmann J.S. Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication. Mol. Cell. Biol. 2009, 29:3344-3354.
73. McDonald J.P., Rapic-Otrin V., Epstein J.A., Broughton B.C., Wang X., Lehmann A.R., Wolgemuth D.J., Woodgate R. Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics 1999, 60:20-30.
74. Dumstorf C.A., Clark A.B., Lin Q., Kissling G.E., Yuan T., Kucherlapati R., McGregor W.G., Kunkel T.A. Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18083-18088.
75. Johnson R.E., Washington M.T., Haracska L., Prakash S., Prakash L. Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. Nature 2000, 406:1015-1019.
76. Lin Q., Clark A.B., McCulloch S.D., Yuan T., Bronson R.T., Kunkel T.A., Kucherlapati R. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Res. 2006, 66:87-94.
77. Ohkumo T., Kondo Y., Yokoi M., Tsukamoto T., Yamada A., Sugimoto T., Kanao R., Higashi Y., Kondoh H., Tatematsu M., Masutani C., Hanaoka F. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota. Mol. Cell. Biol. 2006, 26:7696-7706.
78. Lee G.H., Nishimori H., Sasaki Y., Matsushita H., Kitagawa T., Tokino T. Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2. Oncogene 2003, 22:2374-2382.
79. Wang M., Devereux T.R., Vikis H.G., McCulloch S.D., Holliday W., Anna C., Wang Y., Bebenek K., Kunkel T.A., Guan K., You M. Pol iota is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia. Cancer Res. 2004, 64:1924-1931.
80. Lee G.H., Matsushita H. Genetic linkage between Pol iota deficiency and increased susceptibility to lung tumors in mice. Cancer Sci. 2005, 96:256-259.
81. Obata M., Nishimori H., Ogawa K., Lee G.H. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 1996, 13:1599-1604.
82. Suzuki N., Ohashi E., Kolbanovskiy A., Geacintov N.E., Grollman A.P., Ohmori H., Shibutani S. Translesion synthesis by human DNA polymerase kappa on a DNA template containing a single stereoisomer of dG-(+)- or dG-(-)-anti-N(2)-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene). Biochemistry 2002, 41:6100-6106.
83. Rechkoblit O., Zhang Y., Guo D., Wang Z., Amin S., Krzeminsky J., Louneva N., Geacintov N.E. trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases. J. Biol. Chem. 2002, 277:30488-30494.
84. Zhang Y., Wu X., Guo D., Rechkoblit O., Wang Z. Activities of human DNA polymerase kappa in response to the major benzo[a]pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the lesion. DNA Repair (Amst.) 2002, 1:559-569.
85. Ohashi E., Ogi T., Kusumoto R., Iwai S., Masutani C., Hanaoka F., Ohmori H. Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. Genes Dev. 2000, 14:1589-1594.
86. Ogi T., Limsirichaikul S., Overmeer R.M., Volker M., Takenaka K., Cloney R., Nakazawa Y., Niimi A., Miki Y., Jaspers N.G., Mullenders L.H., Yamashita S., Fousteri M.I., Lehmann A.R. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol. Cell 2010, 37:714-727.
87. Ogi T., Shinkai Y., Tanaka K., Ohmori H. Polkappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15548-15553.
88. Bi X., Slater D.M., Ohmori H., Vaziri C. DNA polymerase kappa is specifically required for recovery from the benzo[a]pyrene-dihydrodiol epoxide (BPDE)-induced S-phase checkpoint. J. Biol. Chem. 2005, 280:22343-22355.
89. Avkin S., Goldsmith M., Velasco-Miguel S., Geacintov N., Friedberg E.C., Livneh Z. Quantitative analysis of translesion DNA synthesis across a benzo[a]pyrene-guanine adduct in mammalian cells: the role of DNA polymerase kappa. J. Biol. Chem. 2004, 279:53298-53305.
90. Ogi T., Lehmann A.R. The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair. Nat. Cell Biol. 2006, 8:640-642.
91. Masuda Y., Takahashi M., Fukuda S., Sumii M., Kamiya K. Mechanisms of dCMP transferase reactions catalyzed by mouse Rev1 protein. J. Biol. Chem. 2002, 277:3040-3046.
92. Nelson J.R., Lawrence C.W., Hinkle D.C. Deoxycytidyl transferase activity of yeast REV1 protein. Nature 1996, 382:729-731.
93. Lin W., Xin H., Zhang Y., Wu X., Yuan F., Wang Z. The human REV1 gene codes for a DNA template-dependent dCMP transferase. Nucleic Acids Res. 1999, 27:4468-4475.
94. Gibbs P.E., Wang X.D., Li Z., McManus T.P., McGregor W.G., Lawrence C.W., Maher V.M. The function of the human homolog of Saccharomyces cerevisiae REV1 is required for mutagenesis induced by UV light. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4186-4191.
95. Ross A.L., Simpson L.J., Sale J.E. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 2005, 33:1280-1289.
96. Jansen J.G., Tsaalbi-Shtylik A., Langerak P., Calleja F., Meijers C.M., Jacobs H., de Wind N. The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis. Nucleic Acids Res. 2005, 33:356-365.
97. Tsaalbi-Shtylik A., Verspuy J.W., Jansen J.G., Rebel H., Carlee L.M., van der Valk M.A., Jonkers J., de Gruijl F.R., de Wind N. Error-prone translesion replication of damaged DNA suppresses skin carcinogenesis by controlling inflammatory hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21836-21841.
98. Murakumo Y., Roth T., Ishii H., Rasio D., Numata S., Croce C.M., Fishel R. A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J. Biol. Chem. 2000, 275:4391-4397.
99. Nelson J.R., Lawrence C.W., Hinkle D.C. Thymine-thymine dimer bypass by yeast DNA polymerase zeta. Science 1996, 272:1646-1649.
100. Van Sloun P.P., Varlet I., Sonneveld E., Boei J.J., Romeijn R.J., Eeken J.C., De Wind N. Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage. Mol. Cell. Biol. 2002, 22:2159-2169.
101. Wittschieben J.P., Reshmi S.C., Gollin S.M., Wood R.D. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res. 2006, 66:134-142.
102. Bemark M., Khamlichi A.A., Davies S.L., Neuberger M.S. Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr. Biol. 2000, 10:1213-1216.
103. Wittschieben J., Shivji M.K., Lalani E., Jacobs M.A., Marini F., Gearhart P.J., Rosewell I., Stamp G., Wood R.D. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr. Biol. 2000, 10:1217-1220.
104. Esposito G., Godindagger I., Klein U., Yaspo M.L., Cumano A., Rajewsky K. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr. Biol. 2000, 10:1221-1224.
105. O-Wang J., Kajiwara K., Kawamura K., Kimura M., Miyagishima H., Koseki H., Tagawa M. An essential role for REV3 in mammalian cell survival: absence of REV3 induces p53-independent embryonic death. Biochem. Biophys. Res. Commun. 2002, 293:1132-1137.
106. Wittschieben J.P., Patil V., Glushets V., Robinson L.J., Kusewitt D.F., Wood R.D. Loss of DNA polymerase zeta enhances spontaneous tumorigenesis. Cancer Res. 2010, 70:2770-2778.
107. Liontos M., Koutsami M., Sideridou M., Evangelou K., Kletsas D., Levy B., Kotsinas A., Nahum O., Zoumpourlis V., Kouloukoussa M., Lygerou Z., Taraviras S., Kittas C., Bartkova J., Papavassiliou A.G., Bartek J., Halazonetis T.D., Gorgoulis V.G. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res. 2007, 67:10899-10909.
108. Zheng L., Dai H., Zhou M., Li M., Singh P., Qiu J., Tsark W., Huang Q., Kernstine K., Zhang X., Lin D., Shen B. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat. Med. 2007, 13:812-819.
109. Feng D., Tu Z., Wu W., Liang C. Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res. 2003, 63:7356-7364.
110. Huang Q.M., Tomida S., Masuda Y., Arima C., Cao K., Kasahara T.A., Osada H., Yatabe Y., Akashi T., Kamiya K., Takahashi T., Suzuki M. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. Cancer Res. 2010, 70:8407-8416.
111. Huang Q.M., Akashi T., Masuda Y., Kamiya K., Takahashi T., Suzuki M. Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochem. Biophys. Res. Commun. 2010, 391:542-546.
112. S. Zhang, H. Chen, X. Zhao, J. Cao, J. Tong, J. Lu, W. Wu, H. Shen, Q. Wei, D. Lu, REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility, Oncogene, , in press. doi:10.1038/onc.2012.32.
113. Fukuoka T., Hibi K., Nakao A. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res. 2006, 26:3333-3335.
114. Hibi K., Nakayama H., Kanyama Y., Kodera Y., Ito K., Akiyama S., Nakao A. Methylation pattern of HLTF gene in digestive tract cancers. Int. J. Cancer 2003, 104:433-436.
115. Leung W.K., Yu J., Bai A.H., Chan M.W., Chan K.K., To K.F., Chan F.K., Ng E.K., Chung S.C., Sung J.J. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer. Mol. Carcinog. 2003, 37:91-97.
116. Oue N., Mitani Y., Motoshita J., Matsumura S., Yoshida K., Kuniyasu H., Nakayama H., Yasui W. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 2006, 106:1250-1259.
117. Moinova H.R., Chen W.D., Shen L., Smiraglia D., Olechnowicz J., Ravi L., Kasturi L., Myeroff L., Plass C., Parsons R., Minna J., Willson J.K., Green S.B., Issa J.P., Markowitz S.D. HLTF gene silencing in human colon cancer. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4562-4567.
118. Capouillez A., Debauve G., Decaestecker C., Filleul O., Chevalier D., Mortuaire G., Coppee F., Leroy X., Belayew A., Saussez S. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology 2009, 55:77-90.
119. Sood R., Makalowska I., Galdzicki M., Hu P., Eddings E., Robbins C.M., Moses T., Namkoong J., Chen S., Trent J.M. Cloning and characterization of a novel gene, SHPRH, encoding a conserved putative protein with SNF2/helicase and PHD-finger domains from the 6q24 region. Genomics 2003, 82:153-161.
120. Kraemer K.H., Lee M.M., Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984, 5:511-514.
121. Kuwamoto K., Miyauchi-Hashimoto H., Isei T., Horio T. Xeroderma pigmentosum variant associated with multiple cancers. Photodermatol. Photoimmunol. Photomed. 1999, 15:127-132.
122. O-Wang J., Kawamura K., Tada Y., Ohmori H., Kimura H., Sakiyama S., Tagawa M. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res. 2001, 61:5366-5369.
123. Bergoglio V., Bavoux C., Verbiest V., Hoffmann J.S., Cazaux C. Localisation of human DNA polymerase kappa to replication foci. J. Cell Sci. 2002, 115:4413-4418.
124. Lowndes N.F., Johnson A.L., Johnston L.H. Coordination of expression of DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature 1991, 350:247-250.
125. Polager S., Kalma Y., Berkovich E., Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002, 21:437-446.
126. Tomida S., Koshikawa K., Yatabe Y., Harano T., Ogura N., Mitsudomi T., Some M., Yanagisawa K., Takahashi T., Osada H. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 2004, 23:5360-5370.
127. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13784-13789.
128. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M., Province M.A., Kraja A., Johnson L.A., Shah K., Sato M., Thomas R.K., Barletta J.A., Borecki I.B., Broderick S., Chang A.C., Chiang D.Y., Chirieac L.R., Cho J., Fujii Y., Gazdar A.F., Giordano T., Greulich H., Hanna M., Johnson B.E., Kris M.G., Lash A., Lin L., Lindeman N., Mardis E.R., McPherson J.D., Minna J.D., Morgan M.B., Nadel M., Orringer M.B., Osborne J.R., Ozenberger B., Ramos A.H., Robinson J., Roth J.A., Rusch V., Sasaki H., Shepherd F., Sougnez C., Spitz M.R., Tsao M.S., Twomey D., Verhaak R.G., Weinstock G.M., Wheeler D.A., Winckler W., Yoshizawa A., Yu S., Zakowski M.F., Zhang Q., Beer D.G., Wistuba I.I., Watson M.A., Garraway L.A., Ladanyi M., Travis W.D., Pao W., Rubin M.A., Gabriel S.B., Gibbs R.A., Varmus H.E., Wilson R.K., Lander E.S., Meyerson M. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
129. Pleasance E.D., Stephens P.J., O'Meara S., McBride D.J., Meynert A., Jones D., Lin M.L., Beare D., Lau K.W., Greenman C., Varela I., Nik-Zainal S., Davies H.R., Ordonez G.R., Mudie L.J., Latimer C., Edkins S., Stebbings L., Chen L., Jia M., Leroy C., Marshall J., Menzies A., Butler A., Teague J.W., Mangion J., Sun Y.A., McLaughlin S.F., Peckham H.E., Tsung E.F., Costa G.L., Lee C.C., Minna J.D., Gazdar A., Birney E., Rhodes M.D., McKernan K.J., Stratton M.R., Futreal P.A., Campbell P.J. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190.